Overview

Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea

Status:
Withdrawn
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
This study is designed as a randomized double-blinded treatment trial among travelers' to geographical areas with moderate-severe rates of traveler's diarrhea. Travelers will be randomized to receive CBS 2004 or masked placebo to be taken daily while traveling. The test article or placebo will be taken starting 7 days prior to travel.
Phase:
Phase 3
Details
Lead Sponsor:
Clasado Biosciences Ltd